Statistical validation of the relationships of cancer pain relief with various factors using ordered logistic regression analysis

Clinical Journal of Pain

Volumn 25, Issue 1, 2009, Pages 65-72

  Kanbayashi, Yuko ^a,b,c   Okamoto, Kousuke ^c   Ogaru, Takanori ^c,e   Hosokawa, Toyoshi ^a   Takagi, Tatsuya ^c,d,f  

^a Palliative Care Unit

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d Research Collaboration Center on Emerging and Re emerging Infections   (Japan)

^e MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^f OSAKA UNIVERSITY   (Japan)

Author keywords

Cancer pain; Ordered logistic regression analysis; Pain relief; Palliative care; Sex differences

Indexed keywords

FENTANYL; MORPHINE; OXYCODONE;

5 POINT VERBAL RATING SCALE; ADULT; AGED; ANALGESIA; ARTICLE; BONE METASTASIS; CANCER PAIN; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN ASSESSMENT; PHARMACIST; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL ANALYSIS; TERMINAL CARE; UNIVERSITY HOSPITAL; VALIDATION STUDY; AGE; BONE TUMOR; INTRACTABLE PAIN; METASTASIS; MIDDLE AGED; NEOPLASM; PALLIATIVE THERAPY; REPRODUCIBILITY; RISK; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; ODDS RATIO; PAIN MEASUREMENT; PAIN, INTRACTABLE; PALLIATIVE CARE; REPRODUCIBILITY OF RESULTS; SEX FACTORS;

EID: 62349087852     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e31817e1379     Document Type: Article

References (51)

1. Larue F, Colleau SM, Brasseur L, et al. Multicentre study of cancer pain and its treatment in France. Br Med J. 1995; 310:10341037.
2. Greenwald HP, Bonica JJ, Bergner M. The prevalence of pain in four cancers. Cancer. 1987;60:25632569.
3. Zenz M, Zenz T, Tryba M, et al. Severe undertreatment of cancer pain: a 3-year survey of the German situation. J Pain Symptom Manage. 1995;10:187191.
4. World Health Organization. Cancer Pain Relief. Geneva: WHO; 1986.
5. Ventafridda V, Tamburini M, Caraceni A, et al. A validation study of the WHO method for cancer pain relief. Cancer. 1987;59:850856.
6. Walker VA, Hoskin PJ, Hanks GW, et al. Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unit. J Pain Symptom Manage. 1988;3:145149.
7. Schug SA, Zech D, Dorr U. Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Manage. 1990;5:2732.
8. Zech DF, Grond S, Lynch J, et al. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain. 1995;63:6576.
9. Mercadante S. Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home. Cancer. 1999;85:18491858.
10. National Cancer Control Programmes. Policies and Managerial Guidelines. 2nd ed. Geneva: WHO; 2002.
11. American Society of Clinical Oncology. Cancer care during the last phase of life. J Clin Oncol. 1998;16:19861996.
12. Twycross R. Symptom Management in Advanced Cancer. Oxford and New York: Radcli?e Med Press; 1995.
13. Mancini I, Dumon JC, Body JJ. E?cacy and safety of ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease: a pilot study. J Clin Oncol. 2004;22:35873592.
14. Mercadante S, Villari P, Ferrera P, et al. Optimization of opioid therapy for preventing incident pain associated with bone metastases. J Pain Symptom Manage. 2004;28:505510.
15. Pinski J, Dor? TB. Prostate cancer metastases to bone: pathophysiology, pain management, and the promise of targeted therapy. Eur J Cancer. 2005;41:932940.
16. Turner SL, Gruenewald S, Spry N, et al, Metastron Users Group. Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer. Br J Cancer. 2001;84:297302.
17. Hillegonds DJ, Franklin S, Shelton DK, et al. The management of painful bone metastases with an emphasis on radionuclide therapy. J Natl Med Assoc. 2007;99:785794.
18. Lam MG, de Klerk JM, van Rijk PP, et al. Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases. Anticancer Agents Med Chem. 2007;7:381397.
19. Liepe K, Kotzerke JA. Comparative study of 188Re-HEDP, 86Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases. Nucl Med Commun. 2007;28:623630.
20. Hoskin PJ. Radiotherapy in symptom management. In: Doyle D, Hanks G, Cherny N, et al, eds. Oxford Textbook of Palliative Medicine. 3rd edn. New York: Oxford University Press; 2005:239255.
21. Kyle RA, Yee GC, Somer?eld MR, et al. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2007;25:24642472.
22. Gnant MF, Mlineritsch B, Luschin-Ebengreuth G, et al. Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer. J Clin Oncol. 2007; 25:820828.
23. Hirsh AT,Waxenberg LB, Atchison JW, et al. Evidence for sex di?erences in the relationships of pain, mood, and disability. J Pain. 2006;17:592601.
24. Ochroch EA, Gottschalk A, Troxel AB. Women su?er more short and long-term pain than men after major thoracotomy. Clin J Pain. 2006;22:491498.
25. Elklit A, Jones A. The association between anxiety and chronic pain after whiplash injury gender-speci?c e?ects. Clin J Pain. 2006;22:487490.
26. Myers CD, Riley JL III, RobinsonME. Psychosocial contributions to sex-correlated di?erences in pain. Clin J Pain. 2003;19:225232.
27. Fillingim RB, Gear RW. Sex di?erences in opioid analgesia: clinical and experimental ?ndings. Eur J Pain. 2004;8:413425.
28. Gear RW, Miaskowski C, Gordon NC, et al. Kappa-opioids produce signi?cantly greater analgesia in women than in men. Nat Med. 1996;2:12481250.
29. Gear RW,Miaskowski C, Gordon NC, et al. The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain. 1999; 83:339345.
30. Binder W, Carmody J, Walker J. E?ect of gender on anti-in?ammatory and analgesic actions of two kappa-opioids. J Pharmacol Exp Ther. 2000;292:303309.
31. al Absi M, Wittmers LE, Ellestad D, et al. Sex di?erences in pain and hypothalamic-pituitary-adrenocortical responses to opioid blockade. Psychosom Med. 2004;66:198206.
32. Edrington JM, Paul S, Dodd M, et al. No evidence for sex di?erences in the severity and treatment of cancer pain. J Pain Symptom Manage. 2004;28:225232.
33. Hallin RG. Pain more painful in women. Gender perspective neglected in research on the biological mechanisms of pain. Lakartidningen. 2003;100:37383741.
34. Unruh AM. Gender variations in clinical pain experience. Pain. 1996;65:123167.
35. Riley JL III, Robinson ME, Wise EA, et al. Sex di?erences in the perception of noxious experimental stimuli: a meta-analysis. Pain. 1998;74:181187.
36. Fillingim RB. Sex, gender, and pain: women and men really are di?erent. Curr Rev Pain. 2000;4:2430.
37. She?eld D, Biles PL, Orom H, et al. Race and sex di?erences in cutaneous pain perception. Psychosom Med. 2000;62:517523.
38. Unruh AM, Ritchie J, Merskey H. Does gender a?ect appraisal of pain and pain coping strategies? Clin J Pain. 1999;15:3140.
39. Uchiyama K, Kawai M, Tani M, et al. Gender di?erences in postoperative pain after laparoscopic cholecystectomy. Surg Endosc. 2006;20:448451.
40. Myers CD, Tsao JC, Glover DA, et al. Sex, gender, and age: contributions to laboratory pain responding in children and adolescents. J Pain. 2006;7:556564.
41. Keogh E, Bond FW, Hanmer R, et al. Comparing acceptance- and control-based coping instructions on the cold-pressor pain experiences of healthy men and women. Eur J Pain. 2005;9: 591598.
42. Keogh E, Mounce C, Brosnan M. Can a sexually dimorphic index of prenatal hormonal exposure be used to examine cold pressor pain perception in men and women? Eur J Pain. 2007;11:231236.
43. Kowalczyk WJ, Evans SM, Bisaga AM, et al. Sex di?erences and hormonal in?uences on response to cold pressor pain in humans. J Pain. 2006;7:151160.
44. Hau M, Dominguez OA, Evrard HC. Testosterone reduces responsiveness to nociceptive stimuli in a wild bird. Horm Behav. 2004;46:165170.
45. Blednov YA, Sto?el M, Alva H, et al. A pervasive mechanism for analgesia: activation of GIRK2 channels. Proc Natl Acad Sci USA. 2003;100:277282.
46. 2-adrenergic analgesia and analgesic sex di?erences. Proc Natl Acad Sci USA. 2003;100:271276.
47. Yelle MD, Rogers JM, Coghill RC. O?set analgesia: a temporal contrast mechanism for nociceptive information. Pain. 2008;134:174186.
48. Koyama T, McHa?e JG, Laurienti PJ, et al. The subjective experience of pain: where expectations become reality. Proc Natl Acad Sci USA. 2005;102:1295012955.
49. Zubieta JK, Heitzeg MM, Smith YR, et al. COMT val158met genotype a?ects mu-opioid neurotransmitter responses to a pain stressor. Science. 2003;299:12401243.
50. Smith YR, Stohler CS, Nichols TE, et al. Pronociceptive and antinociceptive e?ects of estradiol through endogenous opioid neurotransmission in women. J Neurosci. 2006;26: 57775785.
51. Meuser T, Pietruck C, Radbruch L, et al. Symptoms during cancer pain treatment following WHO-guidelines: a long- itudinal follow-up study of symptom prevalence, severity and etiology. Pain. 2001;93:247257.